What is Dror Ortho-Design's earnings per share (EPS)?

Dror Ortho-Design (DROR) reported diluted earnings per share of $0.00 for fiscal year 2025. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Dror Ortho-Design Financials

DROR

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Dror Ortho-Design (DROR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DROR FY2025 2026-05-13

Liquidity compression rather than operating scale now defines the story, as development spending leans on a stretched balance sheet.

The key shift is that cash burn stopped being buffered by new equity and started showing up as balance-sheet stress: cash fell from $3.3M in FY2023 to $229K in FY2025. Over the same stretch, liabilities climbed from $302K to $3.1M, so earlier financing appears to have bought time rather than solved the cash-use pattern.

FY2025's working-capital position is extremely tight: the current ratio was 0.1x and cash was only $229K. The equity cushion also flipped from $3.2M in FY2023 to -$2.9M in FY2025, meaning obligations now sit ahead of shareholders on the balance sheet.

This is not an asset-heavy model: FY2025 capex was only $1K while R&D remained sizable at $816K. That means the funding need comes mainly from ongoing operating and development costs, so liquidity relief would have to come from financing or a smaller expense base, not from pausing major equipment investment.

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Dror Ortho-Design's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

100

Dror Ortho-Design carries a low D/E ratio of -1.09, meaning only $-1.09 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Dror Ortho-Design's current ratio of 0.08 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$0.00

YoY+100.0%

Dror Ortho-Design earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$229K

YoY-61.6%

5Y CAGR-6.6%

Dror Ortho-Design held $229K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

957M

YoY+0.0%

5Y CAGR+36.5%

Dror Ortho-Design had 957M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$816K

YoY-47.0%

Dror Ortho-Design invested $816K in research and development in fiscal year 2025. This represents a decrease of 47.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$966

YoY-96.3%

Dror Ortho-Design invested $966 in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 96.3% from the prior year.

DROR Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	$3K+156.8%	$1K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$816K-47.0%	$1.5M+44.8%	$1.1M+25.0%	$851K	N/A	N/A
SG&A Expenses	N/A	$1.4M+35.5%	$1.1M+30.3%	$815K+735.9%	$97K+11.5%	$87K
Operating Income	N/A	N/A	-$4.4M-159.8%	-$1.7M-889.6%	-$170K-1.5%	-$168K
Interest Expense	N/A	N/A	N/A	$14-93.2%	$207-25.8%	$279
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	-$3.6M-111.9%	-$1.7M-887.3%	-$171K-1.5%	-$168K
EPS (Diluted)	$0.00+100.0%	$-0.010.0%	$-0.01	$0.00	$0.00	$0.00

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$118K	N/A	$151K-53.3%	$324K+35.3%	$240K	N/A	$451K+15.9%	$389K
SG&A Expenses	$379K	N/A	$318K-18.7%	$391K+24.8%	$314K	N/A	$308K-7.7%	$333K
Operating Income	-$497K	N/A	-$470K	N/A	-$576K	N/A	-$1.3M+13.0%	-$1.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$639K	N/A	-$654K	N/A	-$576K	N/A	-$1.8M-21.2%	-$1.5M
EPS (Diluted)	$0.00	N/A	$0.00	$0.00	$0.00	N/A	$0.00	$0.00

DROR Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$259K-60.9%	$663K-80.9%	$3.5M+203.0%	$1.1M+494.4%	$192K-41.4%	$328K
Current Assets	$239K-62.6%	$639K-81.6%	$3.5M+203.6%	$1.1M+492.8%	$192K-41.4%	$328K
Cash & Equivalents	$229K-61.6%	$594K-82.2%	$3.3M+222.2%	$1.0M+458.8%	$186K-42.3%	$322K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	$1K	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.1M+203.9%	$1.0M+240.9%	$302K-44.8%	$547K+126.5%	-$2.1M-394.2%	$703K
Current Liabilities	$3.0M+226.1%	$907K+205.2%	$297K-45.7%	$547K-25.8%	$737K+5.0%	$703K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$2.9M-680.9%	-$368K-111.6%	$3.2M+430.5%	$596K-73.6%	$2.3M+703.2%	-$375K
Retained Earnings	-$22.1M-13.0%	-$19.5M-42.1%	-$13.7M-35.1%	-$10.2M+75.6%	-$41.6M-0.4%	-$41.5M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$254K-2.0%	$259K-4.5%	$271K+104.5%	$133K-70.1%	$443K-33.1%	$663K-47.7%	$1.3M-34.0%	$1.9M
Current Assets	$235K-1.6%	$239K-4.8%	$251K+126.1%	$111K-73.6%	$420K-34.2%	$639K-48.6%	$1.2M-34.4%	$1.9M
Cash & Equivalents	$24K-89.6%	$229K-4.9%	$240K+272.8%	$64K-81.6%	$350K-41.1%	$594K-48.0%	$1.1M-37.7%	$1.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.6M+13.8%	$3.1M+21.0%	$2.6M+44.1%	$1.8M+31.7%	$1.4M+32.4%	$1.0M+15.4%	$893K+239.6%	$263K
Current Liabilities	$3.4M+14.3%	$3.0M+22.1%	$2.4M+47.7%	$1.6M+33.2%	$1.2M+35.7%	$907K+2.1%	$888K+244.2%	$258K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.3M-15.3%	-$2.9M-24.0%	-$2.3M-39.3%	-$1.7M-80.7%	-$921K-150.3%	-$368K-198.3%	$374K-77.4%	$1.7M
Retained Earnings	-$22.7M-2.9%	-$22.1M-2.6%	-$21.5M-3.1%	-$20.8M0.0%	-$20.8M-6.8%	-$19.5M-6.2%	-$18.4M-11.0%	-$16.5M

DROR Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	-$2.7M-14.5%	-$2.4M-57.8%	-$1.5M-1014.8%	-$136K-24.1%	-$110K
Capital Expenditures	$966-96.3%	$26K	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	-$2.8M	N/A	N/A	N/A	N/A
Investing Cash Flow	-$966+96.3%	-$26K-243.9%	$18K	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	$4.7M	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$404K+37.7%	-$649K-53.0%	-$424K+12.6%	-$485K+2.8%	-$500K+11.3%	-$563K+18.5%	-$691K+2.2%	-$706K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$9K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$563K+18.5%	-$691K+3.4%	-$716K
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	$0	$0+100.0%	-$9K
Financing Cash Flow	$200K-69.2%	$650K+8.3%	$600K+200.0%	$200K-33.3%	$300K	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

DROR Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	-6631.7%+10139.0pp	-16770.7%
Net Margin	N/A	N/A	N/A	N/A	-6639.8%+10158.8pp	-16798.6%
Return on Equity	N/A	N/A	-112.8%+169.6pp	-282.4%-274.9pp	-7.5%	N/A
Return on Assets	N/A	N/A	-103.0%+44.2pp	-147.2%-58.6pp	-88.6%-37.4pp	-51.2%
Current Ratio	0.08-0.6	0.70-10.9	11.65+9.6	2.09+1.8	0.26-0.2	0.47
Debt-to-Equity	-1.09+1.7	-2.80-2.9	0.10-0.8	0.92+1.8	-0.91+1.0	-1.88
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	-487.9%-397.0pp	-90.9%
Return on Assets	-251.7%	N/A	-241.0%	N/A	-130.0%	N/A	-144.1%-65.7pp	-78.4%
Current Ratio	0.07-0.0	0.08-0.0	0.10+0.0	0.07-0.3	0.34-0.4	0.70-0.7	1.40-5.9	7.35
Debt-to-Equity	-1.08+0.0	-1.09+0.0	-1.12-0.0	-1.08+0.4	-1.48+1.3	-2.80-5.2	2.38+2.2	0.16
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$2.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.08), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Sack Lunch Prod SAKL

$775K

PEDROS LIST INC PDRO

$6K

American International Holdings AMIH

$20K

Online Vacation ONVC

$15.9M

Grounded People GPAIF

$28.3M

Frequently Asked Questions

What are Dror Ortho-Design's total assets?

Dror Ortho-Design (DROR) had $259K in total assets as of fiscal year 2025, including both current and long-term assets.

What are Dror Ortho-Design's capital expenditures?

Dror Ortho-Design (DROR) invested $966 in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Dror Ortho-Design spend on research and development?

Dror Ortho-Design (DROR) invested $816K in research and development during fiscal year 2025.

How many shares does Dror Ortho-Design have outstanding?

Dror Ortho-Design (DROR) had 957M shares outstanding as of fiscal year 2025.

What is Dror Ortho-Design's current ratio?

Dror Ortho-Design (DROR) had a current ratio of 0.08 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Dror Ortho-Design's debt-to-equity ratio?

Dror Ortho-Design (DROR) had a debt-to-equity ratio of -1.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is Dror Ortho-Design's debt-to-equity ratio negative or unusual?

Dror Ortho-Design (DROR) has negative shareholder equity of -$2.9M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is Dror Ortho-Design?

Dror Ortho-Design (DROR) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.